JP Patent

JP6205133B2 — 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー

Assigned to Boston Childrens Hospital · Expires 2017-09-27 · 9y expired

What this patent protects

Patent listed against ruxolitinib-phosphate.

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: JP6205133B2
Jurisdiction: JP
Classification: —
Expires: 2017-09-27
Drug substance claim: No
Drug product claim: No
Assignee: Boston Childrens Hospital
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.